Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martina Hinterleitner

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|August 12, 2022
NUT Carcinoma-An Underdiagnosed MalignancyUlrich M Lauer, Martina Hinterleitner, Marius Horger, et al.
Journal of Clinical Medicine|October 14, 2022
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma PatientsMoritz Schmidt, Katrin Benzler, Ulrich M Lauer, et al.
Cancers|September 9, 2023
Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance-A Retrospective, Long-Term Single-Center ExperienceMoritz Schmidt, Clemens Hinterleitner, Stephan Singer, et al.
Thoracic Cancer|January 18, 2021
Long-term remission of small cell lung cancer after reactivation of tuberculosis following immune-checkpoint blockade: A case reportMattia Sirgiovanni, Clemens Hinterleitner, Marius Horger, et al.
Cancers|June 2, 2021
Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine MalignanciesMartina Hinterleitner, Bence Sipos, Verena Wagner, et al.
Journal of Clinical Medicine|January 11, 2022
Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell TransplantationMartina Hinterleitner, Clemens Hinterleitner, Elke Malenke, et al.
Anticancer Research|March 31, 2021
Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant CasesRegine Mariette Perl, Johannes Portugall, Clemens Hinterleitner, et al.
Frontiers in Medicine|June 26, 2023
Long-term prognostic factors for PRRT in neuroendocrine tumorsNils Florian Trautwein, Johannes Schwenck, Johann Jacoby, et al.
Journal of Cancer Research and Clinical Oncology|February 7, 2023
NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendotheliomaMoritz Schmidt, Sven Mattern, Stephan Singer, et al.
Experimental and Therapeutic Medicine|October 19, 2023
Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case reportElena Stingu, Jerome-Maurice Dobrowolski, Paula Bombach, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|August 12, 2022
NUT Carcinoma-An Underdiagnosed MalignancyUlrich M Lauer, Martina Hinterleitner, Marius Horger, et al.
Journal of Clinical Medicine|October 14, 2022
Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma PatientsMoritz Schmidt, Katrin Benzler, Ulrich M Lauer, et al.
Cancers|September 9, 2023
Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance-A Retrospective, Long-Term Single-Center ExperienceMoritz Schmidt, Clemens Hinterleitner, Stephan Singer, et al.
Thoracic Cancer|January 18, 2021
Long-term remission of small cell lung cancer after reactivation of tuberculosis following immune-checkpoint blockade: A case reportMattia Sirgiovanni, Clemens Hinterleitner, Marius Horger, et al.
Cancers|June 2, 2021
Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine MalignanciesMartina Hinterleitner, Bence Sipos, Verena Wagner, et al.
Journal of Clinical Medicine|January 11, 2022
Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell TransplantationMartina Hinterleitner, Clemens Hinterleitner, Elke Malenke, et al.
Anticancer Research|March 31, 2021
Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant CasesRegine Mariette Perl, Johannes Portugall, Clemens Hinterleitner, et al.
Frontiers in Medicine|June 26, 2023
Long-term prognostic factors for PRRT in neuroendocrine tumorsNils Florian Trautwein, Johannes Schwenck, Johann Jacoby, et al.
Journal of Cancer Research and Clinical Oncology|February 7, 2023
NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendotheliomaMoritz Schmidt, Sven Mattern, Stephan Singer, et al.
Experimental and Therapeutic Medicine|October 19, 2023
Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case reportElena Stingu, Jerome-Maurice Dobrowolski, Paula Bombach, et al.
Pageof 3